T-box transcription factor, T-bet, has a central role in the differentiation of T-helper (Th) progenitor cells to Th1 or Th2 effector cells, partly by regulating the expression of genes such as interferon-g (IFN-g). However, the direct target genes, especially those mediating the transcriptional network initiated by T-bet, are not yet fully understood. By combining chromatin immunoprecipitation from Th1 cells with human cytosine-phosphate-guanine-island array analysis, Onecut 2 (OC2), which encodes a member of the ONECUT class of transcriptional activators, was identified as a direct target gene of T-bet. OC2 is expressed in Th1 but not Th2 cells and reporter assays showed that T-bet transactivates OC2 transcription through putative T-bet half-sites locating À451 to À347 of OC2 promoter region. Moreover, we found that OC2 binds and transactivates human T-bet promoter. These results suggest that not only cell-extrinsic regulation via the IFN-g/STAT1 pathway, but also cell-intrinsic transcriptional positive feedback loop between T-bet and OC2 could be involved in Th1 development.
Introduction
The differentiation of naive CD4 þ T cells to either T-helper 1 (Th1) or 2 (Th2) effector cells is a critical process during immune responses, with broad implications both in responses to pathogens and in autoimmune and allergic disorders. Transcription factors including Tbet and GATA3 have appeared to play a key role in this process by regulating expression of cytokine genes such as interferon-g (IFN-g) and interleukin-4 (IL-4) that are characterized as dominant factors guiding the development of Th1 and Th2 cells.
1,2 T-bet belongs to a family of transcription factors, the members of which share a highly conserved DNA-binding domain T-box, flanked by diverse non-DNA-binding domains, which are involved in transactivation or repression. [3] [4] [5] [6] A series of studies in vitro and in vivo showed that T-bet is induced by the T-cell receptor and the IFN-gR/STAT1 signaling pathway in antigen-recognizing naive CD4 þ T cells. The elevated T-bet induces IL-12Rb2 and IFN-g expression, allowing IL-12R/STAT4 signaling to optimize IFN-g expression, and thereby amplifying and establishing the effector commitment of Th1 cells. [7] [8] [9] In addition, T-bet induces the expression of homeobox transcription factor, Hlx, and both proteins cooperate to transactivate IFN-g and T-bet expression. 10 Thus, the central roles of T-bet in the cell-extrinsic and -intrinsic pathways involved in Th1 lineage commitment have been well established. However, the direct target genes of T-bet are not yet fully understood. Global analysis of the in vivo effects of protein-DNA interactions on gene expression can be achieved by hybridizing the DNA fragments isolated by a proteinspecific antibody from the cell against a microarray constructed from sequences containing regulatory elements. Taking advantage of the strong association between CpG islands (CGIs) and gene regulatory regions, 11 one type of microarray constructed with CGIs has been established to identify transcription factor target genes. [12] [13] [14] To identify genes that are directly regulated by T-bet in Th1 cells, we employed combinatory analysis of chromatin immunoprecipitation (ChIP) and CGI microarray. We described here that ONECUT class of transcriptional activator OC2 is a target gene of T-bet. T-bet is associated with OC2 promoter and transactivates the expression. Furthermore, there exist OC2-binding elements in human T-bet promoter and OC2 transactivates T-bet expression. Our finding suggests that transcriptional positive feedback loop between T-bet and OC2 could be involved in Th1 development.
Results and discussion
A microarray containing duplicates of 9216 human CGIs was generated and probed with genome fragments isolated by ChIP using an antibody specific to T-bet or an antibody-free control from Th1-polarized human T cells (Figure 1a) . We detected 50 spots at which the signal obtained with T-bet-associated chromatin was at least twofold higher than that obtained by probing with the control chromatin. The end reads of the positive CGI clones were aligned to the human genome sequence using the Blast-like alignment tool obtained from the University of California Santa Cruz Genome Bioinformatics Web site (http://www.genome.ucsc.edu/). The size of the chromatin in the ChIP was approximately 1-3 kb. As a result, 28 genes located within 5 kb of the CGIs were selected for further comparison of their expression in Th1 and Th2 cells by reverse transcription-polymerase chain reaction (RT-PCR) excluding false-positive clones due to repeated elements and/or nonspecific precipitation.
We found higher expression level of the gene encoding the OC2 in Th1 cells compared with Th2 cells (Figure 1b) . The expression patterns of OC2 in hematopoietic lineages, including lymphocytes, have remained unclear, although a previous study reported high expression levels in the brain, testis, liver and skin. 15 We examined the expression of OC2 in various tissues and found the transcript in the thymus and spleen (Figure 1c ). OC2 transcripts were not detected in resting CD4 Figure 1d ). Hence, OC2 seems to be specifically expressed in activated CD4 þ T cells, especially in Th1 cells (Figure 1b and d) .
We next investigated whether T-bet is physically associated with the OC2 promoter in vivo by ChIP experiments using PCR primers specific for OC2 promoter region from À618 to À270. As shown in Figure 1e , genomic DNA fragment including OC2 promoter was coimmunoprecipitated with T-bet from the cell extract of Th1 but not Th2 cells. Thus, OC2 can be a target gene of T-bet in Th1 cells.
To determine whether T-bet directly activates the OC2 gene, a human genome fragment including the OC2 promoter region from À1905 to þ 124 was examined to induce reporter transcription in the presence of T-bet or GATA3 as a control. We found that overexpressed T-bet, but not GATA3, transactivated the reporter through the OC2 promoter region in a dose-dependent manner (Figure 2a) . A similar level of transactivation by T-bet was observed when the OC2 promoter region from À451 to þ 124 was tested, whereas transactivation was markedly decreased in the OC2 promoter region from À347 to þ 124 (Figure 2b ). We did not find the typical consensus-binding sequence for T-box in the region T-bet regulates OC2 transcription K Furuno et al between À451 and À347; however, there are at least three putative consensus half-sites (Supplementary Figure S1 ) that might be functionally similar to a proximal promoter and a distal enhancer of the IFN-g gene. 16 , 17 We could not detect the in vitro binding of T-bet to these sequences (data not shown). However, the introduction of mutations in the first and second half-sites of the OC2 promoter region between À451 and þ 124 reduced the T-bet-mediated transactivation to a similar level as that seen in the OC2 promoter region from À347 to þ 124 in reporter assays (Figure 2c ). Together with the ChIP experiments showing that OC2 promoter À618 to À270 region was coimmunoprecipitated with T-bet (Figure 1e ), our data suggested that OC2 gene was transactivated in conjunction with these sites in cells.
We next examined the effects of truncated mutations of T-bet on transcriptional activation of OC2 promoter in reporter assays. It was found that the transactivation required the T-box DNA-binding domain (Figure 3a ). We also observed that both the N-and C-terminal regions of T-bet were involved in transactivation, although previous reports suggested that the C-terminal alone was an activation domain. 10, 18 Consistent with this observation, when the heterologous GAL4 DNA-binding domain (GAL4DBD) was fused to each region of T-bet, both the N-and C-terminal parts showed transactivation ( Figure 3b ). These results revealed that T-box is flanked by two potent transactivation domains in T-bet. Taken together, our findings indicate that T-bet binds the OC2 promoter via T-box for transactivation in Th1 cells.
Members of the ONECUT class of transcription factors are characterized by a bipartite DNA-binding domain composed of a single cut domain associated with a divergent homeodomain. 19 In mammals, three ONECUT factors, OC1 (HNF6), OC2 and OC3, have been identified so far. The molecular dissection of OC1 revealed that the cut domain and the homeodomain act together to determine DNA-binding affinity, specificity and transactivation. 20 The sequence conservation in these domains among the three paralogues suggests that OC2 binds a similar DNA consensus sequence to OC1. Indeed, many of the OC1 targets are also recognized by OC2. 21 However, the optimal binding sequence for OC2 has not yet been identified. The identification of the target genes of OC2 is essential for elucidating its functional roles in Th1 cells. Thus, we determined the consensusbinding sequence of OC2 through an in vitro selection experiment using a random sequence oligonucleotide and a truncated OC2 protein containing both the cut domain and the homeodomain (Supplementary Figure  S2a) . Five rounds of binding reactions in combination with PCR enriched the DNA species that might interact with OC2 (Figure 4a ). Subsequently, we cloned the PCR products amplified in the final round and analyzed the sequences of 96 clones. We identified 20 different sequences, 16 of which were significantly bound to OC2 in an in vitro band-shift assay (Supplementary Figure S2b) . The alignment of these sequences revealed the consensus, 5 0 -AATCG(A)ATA(C)-3 0 (Figure 4b ), which overlapped significantly with those of the cut domain of human CDP (5 0 -ATCGAT-3 0 ) and OC1 (5 0 -ATCAAT-3 0 ). 20, 22 Based on the consensus-binding sequence of OC2, we searched for candidate target genes encoding proteins related to Th1 function by checking the genome sequences of the promoter region. We found tandem repeats of the consensus sequence 5 0 upstream of the human T-bet gene, 5 0 -ATCAATAAAGATCGAT-3 0 , in the region from À490 to À475 (the consensus sequences are underlined and designated as 'site 1' and 'site 2', Figure S1 ) were mutated in the reporter containing OC2 promoter (À451 to þ 124) and the reporter activities of each construct, as well as the wild-type (top) and OC2 promoter (À347 to þ 124, bottom), were examined in the presence or absence of T-bet in COS7 cells. The relative luciferase activities were calculated by dividing the normalized activities in the presence of T-bet by those in the absence of T-bet.
T-bet regulates OC2 transcription K Furuno et al respectively) (Figure 4c ). OC2 significantly bound this sequence and the interaction was, at best, partially competed by a cold probe containing mutations in site 1 and/or site 2 (Figure 4d ), indicating that both sites were involved in binding to OC2 in vitro.
To examine whether the OC2 transactivates the T-bet promoter, we performed reporter assays using reporter constructs containing T-bet or IFN-g promoter. We found that the reporter gene that contains T-bet promoter (À976 to þ 27), but not the IFN-g promoter, was transactivated by OC2 (Figure 5a ). Furthermore, a ChIP experiment using an OC2-specific antibody, which is able to immunoprecipitate formaldehyde-fixed OC2 protein (Supplementary Figure S3) , revealed an association between OC2 and the T-bet promoter in Th1 cells (Figure 5b) . Thus, these results suggest that T-bet can be a direct target gene of OC2 and is transactivated by this transcription factor in Th1 cells.
Our present study suggests a transcriptional positive feedback loop between T-bet and OC2 in Th1 cells. The endogenous expression of T-bet was shown to be induced by the forced expression of ectopic T-bet, 8 which implied the autoactivation of T-bet, similar to GATA-3. However, a subsequent report revealed that a cell-extrinsic regulatory circuit involving IFN-gR signaling via STAT1 largely maintained the high-level expression of T-bet in developing Th1 cells, rather than a cell-intrinsic pathway of T-bet autoactivation. 9 Because CD4 þ T cells from STAT1-deficient mice still expressed a low level of T-bet and could differentiate into Th1 cells, 23, 24 it is possible that the OC2-mediated transactivation could be involved in the expression of T-bet in a different pathway from STAT1. Alternatively, OC2 could contribute to T-bet expression at some later time during Th1 development, when the stable expression of T-bet is already driven by the IFN-gR/STAT1 pathway. We should also consider the effects of other target genes of OC2 that were not determined in the present study. The studies using OC2-deficient mouse revealed the important roles of this transcription factor in liver and pancreas development, [25] [26] [27] suggesting its broad range of contribution to cellular development.
In conclusion, the present work revealed a new target gene of T-bet, OC2, in Th1 helper T cell, and implies that transcriptional network between T-bet and OC2 coexists with an exocrine mechanism in the complex cellular processes in Th1 development.
Materials and methods

Plasmid constructs
Details of the individual constructs, which were all verified by sequencing, are available upon request. Constructs for mammalian cell transfection were based on pSG5, pCMV-myc (Clontech Laboratories, Mountain View, CS, USA), or pG4MpolyII. The human promoter regions of the T-bet, OC2 and IFN-g gene were cloned to 
Isolation of naive CD4
þ T cells from cord blood Human naive T cells were prepared from cord blood cells of full-term neonates, who had no hereditary disorders, hematological abnormalities or infectious complications, by density-gradient centrifugation. Written informed consent was obtained from all mothers. This study was approved by the ethics committee of Kyushu University. CD4 þ cells were isolated using anti-CD4 monoclonal antibody-coated magnetic beads and an MACS system (Miltenyi Biotec, Bergisch Gladbach, Germany). The expression levels of CD4 and CD45RA were examined by flow cytometry (EPICS XL, Immunotech Coulter, Miami, FL, USA) in each preparation and most cells (495%) were doubly positive.
T-cell stimulation
For the CGI microarray, RT-PCR analysis and ChIP assay,
) were stimulated with 1 mg ml À1 PHA (Wako Pure Chemical Industries, Osaka, Japan) and 50 U ml À1 recombinant human IL-2 (Shionogi, Osaka, Japan) in the presence of either 10 ng ml À1 recombinant human IL-12 (R&D Systems, Minneapolis, MN, USA) and 10 mg ml À1 anti-human IL-4 (R&D Systems), or 20 ng ml À1 human IL-4 (Pepro Tech, Rocky Hill, NJ, USA) and 10 mg ml À1 anti-human IL-12 (R&D Systems), for Th1 or Th2 differentiation, respectively. After 3 days of culture, the cells were restimulated with 20 nM of PMA (Sigma-Aldrich, St Louis, MO, USA) and 1 mM of ionomycin (Sigma) for 4 h, and then harvested for the experiments.
ChIP assay
The ChIP assay was performed as described previously 28 using a ChIP Assay Kit (Upstate, Lake Placid, NY, USA). Approximately 10 7 cells were used for each assay. Anti-T-bet (4B10, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-OC2 antibodies produced against human OC2-derived peptide, 44-ASPSPHHARR-53, were used. Glutathione S-transferase (GST) or GST-OC2 (296-485) were subjected to band-shift assay with a labeled probe of the T-bet promoter region from À497 to À468 (wild-type, WT) in the presence or absence of the indicated nonlabeled competitor. The mut1, mut2 and mut3 probes contained mutations in site 1, site 2 and both sites, respectively. 
T-bet
CGI microarray
The human CGI library was purchased from the UK Human Genome Mapping Project Resource Centre. A total of 9216 clones were organized individually in 96-well plates. The CGI inserts were amplified by PCR using the 5 0 -CGGCCGCCTGCAGGTCGACCTTAA-3 0 and 5 0 -AACGCGTTGGGAGCTCTCCCTTAA-3 0 primers. 29 The PCR products were purified using Magnesil (Promega, Madison, WI, USA) and then mixed with dimethyl sulfoxide (DMSO) to a final concentration of 10%. Array Spotter Generation III (Molecular Dynamics, Sunnyvale, CA, USA) was used to assemble the PCR/ dimethyl sulfoxide samples on microarray slides (Type 7 Star; Amersham) as microdots (spot diameter ¼ 250 ml and spot buffer ¼ 30 ml). A total of four individual ChIP assays were performed with anti-T-bet antibody or no antibody, using approximately 10 7 cells for each experiment. The combined test or control samples were labeled according to the protocols developed by DeRisi et al.
(Microarrays.org, http://www.derisilab.ucsf.edu/data/ microarray/index.html) and hybridized with microarray slides using an automated slide processor (Amersham). The slides were scanned with the GenePix 4000A (Axon) and the images were analyzed with GenePix Pro 3.0 software. Spots showing a Cy5/Cy3 ratio in duplicate42 were selected as positive. Reporter assay Reporter plasmids (1 mg), phRL-CMV (50 ng, internal control for transfection efficiency) and effector plasmids (2 mg) were used in all reporter assays except that indicated amounts of effector were transfected in the assay shown in Figure 2a . Firefly and Renilla luciferase activities were measured sequentially using a dual luciferase reporter-assay system (Promega). Transfection efficiencies were normalized to the Renilla luciferase activity.
In vitro binding site selection HA-tagged OC2 protein containing the cut domain and the homeodomain was generated by an in vitro transcription/translation system (Promega) and purified by immunoprecipitation with anti-HA antibody coupled to protein G. Double-stranded oligonucleotides containing 20-nt random sequences were generated based on oligo N20 extended by primer B and Klenow DNA polymerase (Supplementary Figure S2a) . The immunoprecipitates were preincubated with 0.1 mg ml À1 of poly(dI-dC) in binding buffer (50 mM Tris-HCl (pH 7.5), 50 mM NaCl, 5% glycerol and 1 mM DTT), and approximately 1 mg of double-stranded oligo N20 was added for further incubation. The protein G beads were washed and the bound DNA was purified by phenol/chloroform extraction. The purified DNA was amplified by 15 cycles of PCR using primers A and B (Supplementary Figure S2a) . The PCR products were used for the next round of incubation. This reaction was repeated five times and the final PCR products were cloned for sequencing.
Band-shift assay Purification of the GST and GST-OC2 (296-485) proteins were performed as previously described. 30 Approximately 50 ng of protein was preincubated with 0.1 mg ml À1 of poly(dI-dC) for 5 min in binding buffer, and 0.3 pmol of the indicated oligonucleotide probe labeled with biotin at the 5 0 end of one of strand was added for further incubation. For the competition assay, 0.3 or 1.5 pmol of nonlabeled competitor was added to the reaction mixture before incubation with the labeled probe. The samples were loaded onto a 10% polyacrylamide gel, transferred onto a nylon membrane (Hybond-N þ ; Amersham) and visualized using avidin peroxidase by standard protocol for western blotting.
